Cipla Gets USFDA Nod for Generic Lanreotide Injection
May 22, 2024 12:13
Cipla receives USFDA approval to market generic Lanreotide injection, a treatment for acromegaly and other conditions. The drug is a therapeutic equivalent to Somatuline Depot Injection.